Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001133416-24-000028
Filing Date
2024-02-07
Accepted
2024-02-07 16:55:59
Documents
1
Period of Report
2024-01-24

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3714
  Complete submission text file 0001133416-24-000028.txt   5261
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 467 N. COUNTRY RIDGE CT. LAKE ZURICH IL 60047
Business Address
Zordani Richard A. Jr. (Reporting) CIK: 0001827180 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31791 | Film No.: 24605040